The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Puerarin for Injection Market Research Report 2025
Synopsis
Puerarin for Injection is a pharmaceutical product derived from the root of the kudzu plant (Pueraria lobata), traditionally used in Chinese medicine. Puerarin contains bioactive compounds such as isoflavones, particularly puerarin, known for its antioxidant, vasodilatory, and neuroprotective properties. This injectable form of puerarin is used in the treatment of cardiovascular diseases, including coronary artery disease, hypertension, and angina pectoris. It improves blood flow, reduces oxidative stress, and enhances cardiac function, making it beneficial for patients with cardiovascular conditions. Puerarin injections are administered in hospitals and clinics as an adjunct therapy for managing cardiovascular risk factors and preventing cardiovascular events.
The global Puerarin for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The industry trend for Puerarin for Injection reflects a growing interest in natural remedies and botanical medicines for cardiovascular health and disease prevention. With a shift towards holistic approaches to healthcare, there's increasing demand for plant-derived therapeutics like puerarin that offer cardiovascular benefits with potentially fewer side effects compared to conventional medications. Pharmaceutical companies are investing in research and development to explore the pharmacological properties and therapeutic applications of puerarin and its derivatives in cardiovascular medicine. Additionally, there's a focus on developing standardized formulations and quality control measures to ensure the safety, efficacy, and reproducibility of puerarin injections, driving their integration into evidence-based treatment protocols for cardiovascular diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Puerarin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Puerarin for Injection.
The Puerarin for Injection market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Puerarin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Puerarin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Procurenet
Actiza Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
You Care
Harbin Sanlian Pharmaceutical
Beijing Sihuan Kebao Pharmaceutical
Hubei Tianyao Pharmaceutical
Segment by Type
0.1g
0.2g
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Puerarin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Puerarin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Puerarin for Injection is a pharmaceutical product derived from the root of the kudzu plant (Pueraria lobata), traditionally used in Chinese medicine. Puerarin contains bioactive compounds such as isoflavones, particularly puerarin, known for its antioxidant, vasodilatory, and neuroprotective properties. This injectable form of puerarin is used in the treatment of cardiovascular diseases, including coronary artery disease, hypertension, and angina pectoris. It improves blood flow, reduces oxidative stress, and enhances cardiac function, making it beneficial for patients with cardiovascular conditions. Puerarin injections are administered in hospitals and clinics as an adjunct therapy for managing cardiovascular risk factors and preventing cardiovascular events.
The global Puerarin for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The industry trend for Puerarin for Injection reflects a growing interest in natural remedies and botanical medicines for cardiovascular health and disease prevention. With a shift towards holistic approaches to healthcare, there's increasing demand for plant-derived therapeutics like puerarin that offer cardiovascular benefits with potentially fewer side effects compared to conventional medications. Pharmaceutical companies are investing in research and development to explore the pharmacological properties and therapeutic applications of puerarin and its derivatives in cardiovascular medicine. Additionally, there's a focus on developing standardized formulations and quality control measures to ensure the safety, efficacy, and reproducibility of puerarin injections, driving their integration into evidence-based treatment protocols for cardiovascular diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Puerarin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Puerarin for Injection.
The Puerarin for Injection market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Puerarin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Puerarin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Procurenet
Actiza Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
You Care
Harbin Sanlian Pharmaceutical
Beijing Sihuan Kebao Pharmaceutical
Hubei Tianyao Pharmaceutical
Segment by Type
0.1g
0.2g
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Puerarin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Puerarin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Puerarin for Injection Market Overview
1.1 Product Definition
1.2 Puerarin for Injection by Type
1.2.1 Global Puerarin for Injection Market Value Comparison by Type (2024-2030)
1.2.2 0.1g
1.2.3 0.2g
1.2.4 Others
1.3 Puerarin for Injection by Application
1.3.1 Global Puerarin for Injection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Puerarin for Injection Market Size Estimates and Forecasts
1.4.1 Global Puerarin for Injection Revenue 2019-2030
1.4.2 Global Puerarin for Injection Sales 2019-2030
1.4.3 Global Puerarin for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Puerarin for Injection Market Competition by Manufacturers
2.1 Global Puerarin for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Puerarin for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Puerarin for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Puerarin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Puerarin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Puerarin for Injection, Product Type & Application
2.7 Global Key Manufacturers of Puerarin for Injection, Date of Enter into This Industry
2.8 Global Puerarin for Injection Market Competitive Situation and Trends
2.8.1 Global Puerarin for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Puerarin for Injection Players Market Share by Revenue
2.8.3 Global Puerarin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Puerarin for Injection Market Scenario by Region
3.1 Global Puerarin for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Puerarin for Injection Sales by Region: 2019-2030
3.2.1 Global Puerarin for Injection Sales by Region: 2019-2024
3.2.2 Global Puerarin for Injection Sales by Region: 2025-2030
3.3 Global Puerarin for Injection Revenue by Region: 2019-2030
3.3.1 Global Puerarin for Injection Revenue by Region: 2019-2024
3.3.2 Global Puerarin for Injection Revenue by Region: 2025-2030
3.4 North America Puerarin for Injection Market Facts & Figures by Country
3.4.1 North America Puerarin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Puerarin for Injection Sales by Country (2019-2030)
3.4.3 North America Puerarin for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Puerarin for Injection Market Facts & Figures by Country
3.5.1 Europe Puerarin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Puerarin for Injection Sales by Country (2019-2030)
3.5.3 Europe Puerarin for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Puerarin for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Puerarin for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Puerarin for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Puerarin for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Puerarin for Injection Market Facts & Figures by Country
3.7.1 Latin America Puerarin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Puerarin for Injection Sales by Country (2019-2030)
3.7.3 Latin America Puerarin for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Puerarin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Puerarin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Puerarin for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Puerarin for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Puerarin for Injection Sales by Type (2019-2030)
4.1.1 Global Puerarin for Injection Sales by Type (2019-2024)
4.1.2 Global Puerarin for Injection Sales by Type (2025-2030)
4.1.3 Global Puerarin for Injection Sales Market Share by Type (2019-2030)
4.2 Global Puerarin for Injection Revenue by Type (2019-2030)
4.2.1 Global Puerarin for Injection Revenue by Type (2019-2024)
4.2.2 Global Puerarin for Injection Revenue by Type (2025-2030)
4.2.3 Global Puerarin for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Puerarin for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Puerarin for Injection Sales by Application (2019-2030)
5.1.1 Global Puerarin for Injection Sales by Application (2019-2024)
5.1.2 Global Puerarin for Injection Sales by Application (2025-2030)
5.1.3 Global Puerarin for Injection Sales Market Share by Application (2019-2030)
5.2 Global Puerarin for Injection Revenue by Application (2019-2030)
5.2.1 Global Puerarin for Injection Revenue by Application (2019-2024)
5.2.2 Global Puerarin for Injection Revenue by Application (2025-2030)
5.2.3 Global Puerarin for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Puerarin for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Procurenet
6.1.1 Procurenet Company Information
6.1.2 Procurenet Description and Business Overview
6.1.3 Procurenet Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Procurenet Puerarin for Injection Product Portfolio
6.1.5 Procurenet Recent Developments/Updates
6.2 Actiza Pharmaceutical
6.2.1 Actiza Pharmaceutical Company Information
6.2.2 Actiza Pharmaceutical Description and Business Overview
6.2.3 Actiza Pharmaceutical Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Actiza Pharmaceutical Puerarin for Injection Product Portfolio
6.2.5 Actiza Pharmaceutical Recent Developments/Updates
6.3 Chengdu Tiantai Mountain Pharmaceutical
6.3.1 Chengdu Tiantai Mountain Pharmaceutical Company Information
6.3.2 Chengdu Tiantai Mountain Pharmaceutical Description and Business Overview
6.3.3 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product Portfolio
6.3.5 Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates
6.4 You Care
6.4.1 You Care Company Information
6.4.2 You Care Description and Business Overview
6.4.3 You Care Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 You Care Puerarin for Injection Product Portfolio
6.4.5 You Care Recent Developments/Updates
6.5 Harbin Sanlian Pharmaceutical
6.5.1 Harbin Sanlian Pharmaceutical Company Information
6.5.2 Harbin Sanlian Pharmaceutical Description and Business Overview
6.5.3 Harbin Sanlian Pharmaceutical Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Harbin Sanlian Pharmaceutical Puerarin for Injection Product Portfolio
6.5.5 Harbin Sanlian Pharmaceutical Recent Developments/Updates
6.6 Beijing Sihuan Kebao Pharmaceutical
6.6.1 Beijing Sihuan Kebao Pharmaceutical Company Information
6.6.2 Beijing Sihuan Kebao Pharmaceutical Description and Business Overview
6.6.3 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product Portfolio
6.6.5 Beijing Sihuan Kebao Pharmaceutical Recent Developments/Updates
6.7 Hubei Tianyao Pharmaceutical
6.7.1 Hubei Tianyao Pharmaceutical Company Information
6.7.2 Hubei Tianyao Pharmaceutical Description and Business Overview
6.7.3 Hubei Tianyao Pharmaceutical Puerarin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hubei Tianyao Pharmaceutical Puerarin for Injection Product Portfolio
6.7.5 Hubei Tianyao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Puerarin for Injection Industry Chain Analysis
7.2 Puerarin for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Puerarin for Injection Production Mode & Process
7.4 Puerarin for Injection Sales and Marketing
7.4.1 Puerarin for Injection Sales Channels
7.4.2 Puerarin for Injection Distributors
7.5 Puerarin for Injection Customers
8 Puerarin for Injection Market Dynamics
8.1 Puerarin for Injection Industry Trends
8.2 Puerarin for Injection Market Drivers
8.3 Puerarin for Injection Market Challenges
8.4 Puerarin for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Puerarin for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Puerarin for Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Puerarin for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Puerarin for Injection Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Puerarin for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Puerarin for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Puerarin for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Puerarin for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Puerarin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Puerarin for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Puerarin for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Puerarin for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Puerarin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Puerarin for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Puerarin for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Puerarin for Injection Sales by Region (2019-2024) & (Units)
Table 18. Global Puerarin for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Puerarin for Injection Sales by Region (2025-2030) & (Units)
Table 20. Global Puerarin for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Puerarin for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Puerarin for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Puerarin for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Puerarin for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Puerarin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 27. North America Puerarin for Injection Sales by Country (2025-2030) & (Units)
Table 28. North America Puerarin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Puerarin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Puerarin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 32. Europe Puerarin for Injection Sales by Country (2025-2030) & (Units)
Table 33. Europe Puerarin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Puerarin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Puerarin for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Puerarin for Injection Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Puerarin for Injection Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Puerarin for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Puerarin for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Puerarin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 42. Latin America Puerarin for Injection Sales by Country (2025-2030) & (Units)
Table 43. Latin America Puerarin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Puerarin for Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Puerarin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Puerarin for Injection Sales by Country (2019-2024) & (Units)
Table 47. Middle East and Africa Puerarin for Injection Sales by Country (2025-2030) & (Units)
Table 48. Middle East and Africa Puerarin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Puerarin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Puerarin for Injection Sales (Units) by Type (2019-2024)
Table 51. Global Puerarin for Injection Sales (Units) by Type (2025-2030)
Table 52. Global Puerarin for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Puerarin for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Puerarin for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Puerarin for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Puerarin for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Puerarin for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Puerarin for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Puerarin for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Puerarin for Injection Sales (Units) by Application (2019-2024)
Table 61. Global Puerarin for Injection Sales (Units) by Application (2025-2030)
Table 62. Global Puerarin for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Puerarin for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Puerarin for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Puerarin for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Puerarin for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Puerarin for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Puerarin for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Puerarin for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Procurenet Company Information
Table 71. Procurenet Description and Business Overview
Table 72. Procurenet Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Procurenet Puerarin for Injection Product
Table 74. Procurenet Recent Developments/Updates
Table 75. Actiza Pharmaceutical Company Information
Table 76. Actiza Pharmaceutical Description and Business Overview
Table 77. Actiza Pharmaceutical Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Actiza Pharmaceutical Puerarin for Injection Product
Table 79. Actiza Pharmaceutical Recent Developments/Updates
Table 80. Chengdu Tiantai Mountain Pharmaceutical Company Information
Table 81. Chengdu Tiantai Mountain Pharmaceutical Description and Business Overview
Table 82. Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product
Table 84. Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates
Table 85. You Care Company Information
Table 86. You Care Description and Business Overview
Table 87. You Care Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. You Care Puerarin for Injection Product
Table 89. You Care Recent Developments/Updates
Table 90. Harbin Sanlian Pharmaceutical Company Information
Table 91. Harbin Sanlian Pharmaceutical Description and Business Overview
Table 92. Harbin Sanlian Pharmaceutical Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Harbin Sanlian Pharmaceutical Puerarin for Injection Product
Table 94. Harbin Sanlian Pharmaceutical Recent Developments/Updates
Table 95. Beijing Sihuan Kebao Pharmaceutical Company Information
Table 96. Beijing Sihuan Kebao Pharmaceutical Description and Business Overview
Table 97. Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product
Table 99. Beijing Sihuan Kebao Pharmaceutical Recent Developments/Updates
Table 100. Hubei Tianyao Pharmaceutical Company Information
Table 101. Hubei Tianyao Pharmaceutical Description and Business Overview
Table 102. Hubei Tianyao Pharmaceutical Puerarin for Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Hubei Tianyao Pharmaceutical Puerarin for Injection Product
Table 104. Hubei Tianyao Pharmaceutical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Puerarin for Injection Distributors List
Table 108. Puerarin for Injection Customers List
Table 109. Puerarin for Injection Market Trends
Table 110. Puerarin for Injection Market Drivers
Table 111. Puerarin for Injection Market Challenges
Table 112. Puerarin for Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Puerarin for Injection
Figure 2. Global Puerarin for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Puerarin for Injection Market Share by Type: 2023 & 2030
Figure 4. 0.1g Product Picture
Figure 5. 0.2g Product Picture
Figure 6. Others Product Picture
Figure 7. Global Puerarin for Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Puerarin for Injection Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Puerarin for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Puerarin for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Puerarin for Injection Sales (2019-2030) & (Units)
Figure 14. Global Puerarin for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Puerarin for Injection Report Years Considered
Figure 16. Puerarin for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Puerarin for Injection Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Puerarin for Injection Players: Market Share by Revenue in Puerarin for Injection in 2023
Figure 19. Puerarin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Puerarin for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Puerarin for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Puerarin for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Puerarin for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Puerarin for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Puerarin for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Puerarin for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Puerarin for Injection Sales Market Share by Country (2019-2030)
Figure 42. Mexico Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Puerarin for Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Puerarin for Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Puerarin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Puerarin for Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Puerarin for Injection by Type (2019-2030)
Figure 53. Global Puerarin for Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Puerarin for Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Puerarin for Injection by Application (2019-2030)
Figure 56. Global Puerarin for Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Puerarin for Injection Value Chain
Figure 58. Puerarin for Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
